Atrioventricular (AV) Conduction Defects

Atrioventricular conduction defects are problems with the heart’s “electrical wiring” between the upper chambers (atria) and lower chambers (ventricles). Signals normally pass through a relay station called the AV node and then into the His-Purkinje system so the heart beats in order. If signals are slowed or blocked, the heartbeat can become slow, irregular, or even stop briefly. Doctors group AV block into first-degree (slow signal), second-degree (some signals lost—Mobitz I/Wenckebach and Mobitz II), and third-degree or “complete” heart block (no signals get through). Serious blocks can cause fainting and need a pacemaker. Merck Manuals+2NCBI+2

Your heart’s top chambers (atria) send tiny electrical signals to the bottom chambers (ventricles) through a “gateway” called the atrioventricular (AV) node and the bundle of His–Purkinje system. In an AV conduction defect, these signals are slowed, intermittently blocked, or fully blocked on their way from atria to ventricles. This can make the heart beat too slowly, beat irregularly, or skip beats. How serious it is depends on how much and where the signal is blocked. Doctors diagnose AV conduction defects with an electrocardiogram (ECG) and related heart-rhythm tests. Treatment ranges from watchful follow-up to a pacemaker when the block is dangerous or causes symptoms. AHA Journals+2NCBI+2

Other names

• AV block

• Atrioventricular block

• Heart block (a general lay term that often means AV block)

• First-degree AV block (PR interval is long but every beat gets through)

• Second-degree AV block (some beats do not get through)

  • Mobitz I (Wenckebach)

  • Mobitz II

• Third-degree (complete) AV block (no atrial signals get through; ventricles beat on their own)

• Nodal block (at the AV node) vs infranodal block (below the node—His bundle or bundle branches)
  These names describe where the block is and how much the signal is delayed or lost. NCBI+1

Types

1. By degree (how much signal is blocked)

• First-degree: The signal is slow, but none are dropped. ECG shows a long PR interval. Often no symptoms. Merck Manuals

• Second-degree Mobitz I (Wenckebach): PR gets longer and longer, then one beat drops. Often at the AV node; sometimes normal during sleep or in athletes; can be benign if asymptomatic. Merck Manuals

• Second-degree Mobitz II: Some beats drop without gradual lengthening. Often below the AV node (His–Purkinje). More serious; can progress to complete block. Merck Manuals

• Third-degree (complete): No atrial signals reach the ventricles. The ventricles pace themselves slowly. This is usually urgent and often needs a pacemaker. NCBI

2. By location

• Nodal (AV-nodal): Usually slower, often less dangerous, can respond to atropine; often shows narrow QRS. AHA Journals

• Infranodal (His–Purkinje): Often more dangerous, wide QRS, higher pacemaker need. AHA Journals

3. By cause

• Congenital (present at birth) vs acquired (develops later). Congenital forms can be linked to maternal autoantibodies. Acquired forms include age-related fibrosis, heart attacks, infections, and drugs (details below). Merck Manuals

---

Causes

1. Age-related degeneration (fibrosis) of the conduction system
   Natural wear of the AV node/His–Purkinje tissue causes slow or blocked signals, especially in older adults. Merck Manuals

2. Coronary artery disease and heart attack (myocardial infarction)
   Reduced blood flow injures conduction tissue. Inferior MI often causes transient nodal block; anterior MI can damage the His–Purkinje system and lead to serious, persistent block. AHA Journals

3. Medications that slow AV conduction
   Examples: beta-blockers, non-dihydropyridine calcium-channel blockers (verapamil, diltiazem), digoxin, amiodarone, class I antiarrhythmics, adenosine. They intentionally slow the AV node but can push a vulnerable system into block. AHA Journals

4. High vagal tone
   During sleep, in trained athletes, or with pain/straining, the vagus nerve can slow AV conduction and produce Wenckebach or pauses. Usually benign if no symptoms. Merck Manuals

5. Electrolyte disorders (especially hyperkalemia)
   High potassium depresses conduction and can cause AV block; severe hypokalemia or hypermagnesemia may also contribute. Merck Manuals

6. Myocarditis (inflammation of the heart muscle)
   Viral or immune inflammation temporarily injures AV tissue and His–Purkinje pathways. AHA Journals

7. Lyme carditis (Borrelia infection)
   A classic reversible cause of high-grade AV block in endemic areas; requires antibiotic therapy and short-term pacing if unstable. JACC+1

8. Cardiac sarcoidosis
   Granulomas infiltrate the conduction system and cause AV block, often high grade; evaluation may include cardiac MRI or FDG-PET; steroids may be used along with pacing/ICD when indicated. Oxford Academic

9. Amyloidosis
   Protein deposits stiffen and disrupt electrical tissue, leading to bradyarrhythmias and AV block. Oxford Academic

10. Chagas disease (Trypanosoma cruzi)
    A common cause of conduction disease in endemic regions; can cause AV and bundle-branch blocks. AHA Journals

11. After cardiac surgery or transcatheter valve procedures (e.g., TAVR)
    Mechanical trauma, edema, or local ischemia near the conduction system can create new AV block; some resolve, others need pacing. Oxford Academic

12. Post-catheter ablation near the AV node
    Ablation for AVNRT or septal tachycardias can rarely damage the AV node and cause block. AHA Journals

13. Congenital AV block (including maternal anti-Ro/SSA antibodies)
    Babies can be born with AV block; maternal autoimmune antibodies may cross the placenta and injure fetal conduction tissue. Merck Manuals

14. Endocarditis with abscess near the AV node
    Infection can extend to the septum and interrupt conduction. Merck Manuals

15. Infiltrative/storage diseases (hemochromatosis, Fabry, etc.)
    Abnormal deposits disrupt the conduction network. Oxford Academic

16. Radiation therapy to the chest
    Late scarring from radiation can cause conduction disease years later. Oxford Academic

17. Hypothyroidism
    Low thyroid levels slow heart rate and can worsen AV nodal delay in susceptible patients. Merck Manuals

18. Sleep apnea
    Recurrent hypoxia and vagal surges at night can trigger bradyarrhythmias and AV block episodes; treating apnea often helps. AHA Journals

19. Cardiomyopathies (dilated, hypertrophic, restrictive)
    Structural heart changes and septal fibrosis can involve the conduction system. Oxford Academic

20. Chest trauma
    Direct injury to the septum or conduction tissue can cause transient or permanent block. Merck Manuals

---

Common symptoms and day-to-day signs

1. No symptoms (especially with first-degree or Mobitz I): many people feel fine. Merck Manuals

2. Tiredness: low heart rate lowers blood flow and energy. Merck Manuals

3. Light-headedness or dizziness: brain gets less blood during dropped beats. Merck Manuals

4. Near-fainting (presyncope): brief loss of strength or vision. Merck Manuals

5. Fainting (syncope): more likely with Mobitz II or complete block. NCBI

6. Slow pulse (bradycardia): home devices may show low heart rate. Merck Manuals

7. Palpitations: awareness of irregular or skipped beats. Merck Manuals

8. Shortness of breath, especially on exertion: heart cannot raise output enough. Merck Manuals

9. Chest discomfort: from strain or coexisting heart disease. Merck Manuals

10. Exercise intolerance: fatigue early during activity. AHA Journals

11. Confusion or “brain fog” in older adults during slow rhythms. Merck Manuals

12. Headaches after exertion in some patients due to low output. Merck Manuals

13. Swelling in legs or ankles if heart failure worsens due to slow heart rate. Oxford Academic

14. Cannon “A” waves in the neck (jugular bulges) with complete AV dissociation. Merck Manuals

15. In infants/children: poor feeding, irritability, or bluish color with severe block. Merck Manuals

---

Diagnostic tests

A) Physical examination

1. Pulse and blood pressure check
   The doctor counts the heart rate, looks for pauses or irregularity, and checks if blood pressure drops with symptoms. A very slow, regular pulse suggests AV block. Merck Manuals

2. Auscultation (listening with a stethoscope)
   Variable S1 (first heart sound) intensity and slow rhythm can hint at AV dissociation in complete block. Merck Manuals

3. Neck vein (jugular) exam
   Large, sudden neck vein pulsations—cannon A waves—appear when atria and ventricles beat independently (complete block). Merck Manuals

4. Orthostatic vitals and general exam
   Checks for dizziness on standing, signs of heart failure (leg swelling, crackles), thyroid enlargement, or medication patch use (e.g., beta-blocker). Oxford Academic

B) Manual/bedside maneuvers

5. Valsalva maneuver
   Short, gentle straining boosts vagal tone and may worsen nodal block (Wenckebach), helping identify an AV-nodal pattern; not for unstable patients. AHA Journals

6. Carotid sinus massage (with caution)
   In supervised settings, brief pressure at the carotid sinus can increase vagal tone and unmask nodal block patterns; never used if carotid disease is suspected. AHA Journals

7. Atropine challenge (bedside pharmacologic test)
   Atropine reduces vagal tone. If conduction improves, block is likely at the AV node; little change suggests infranodal disease. AHA Journals

8. Exercise (walk or treadmill) response
   Rate-related improvement suggests nodal involvement; worsening conduction or new bundle-branch changes with exercise may point to infranodal disease. AHA Journals

C) Laboratory and pathological tests

9. Electrolytes (potassium, magnesium, calcium)
   Finds hyperkalemia or other imbalances that depress conduction and can be corrected. Merck Manuals

10. Thyroid-stimulating hormone (TSH)
    Low thyroid function can contribute to bradycardia and AV delay; treatable if found. Merck Manuals

11. Cardiac enzymes (high-sensitivity troponin)
    Detects active heart attack or myocarditis damaging conduction tissue. AHA Journals

12. Drug levels/toxicology (e.g., digoxin level)
    Too much digoxin or combinations of AV-slowing drugs can precipitate block. AHA Journals

13. Infection/immune testing when suspected
    Examples: Lyme serology in endemic areas; autoimmune markers (anti-Ro/SSA) in congenital/neonatal block; tailored to history and region. Infectious Diseases Society of America+1

14. Chagas testing (in at-risk patients)
    Serology is used when exposure is possible; conduction disease is common in chronic Chagas. AHA Journals

D) Electrodiagnostic tests (the core of diagnosis)

15. 12-lead ECG
    This is the key test. It shows PR interval (first-degree), dropped beats and patterns (Mobitz I vs II), or complete AV dissociation (third-degree). It also hints at where the block is (narrow vs wide QRS) and shows ischemia or prior infarct. Merck Manuals

16. Ambulatory monitoring (Holter 24–48 h)
    Captures intermittent blocks, night-time episodes, and links symptoms to rhythm. AHA Journals

17. Event monitor / external loop recorder
    Used for less frequent spells; patient activates or device auto-records when rhythm slows or pauses. AHA Journals

18. Implantable loop recorder (ILR)
    A tiny device under the skin records rhythm for months to years—helpful when fainting is rare and diagnosis is unclear. AHA Journals

19. Electrophysiology study (EPS) with His-bundle recordings
    Catheters map conduction times (AH, HV intervals) to pinpoint nodal vs infranodal disease. A long HV or induced block suggests high pacemaker need. AHA Journals

E) Imaging tests

20. Transthoracic echocardiogram (heart ultrasound)
    Looks for structural heart disease (valve disease, septal thickness, ventricular function) that can coexist with or cause conduction problems. Oxford Academic

21. Cardiac MRI
    Detects myocarditis, sarcoidosis, amyloidosis, or scar involving the septum and conduction pathways. Oxford Academic

22. FDG-PET (when sarcoidosis is suspected)
    Shows active inflammation in the heart and guides therapy and device decisions. Oxford Academic

23. Coronary imaging (CT angiography or invasive angiography)
    Used when heart-attack–related conduction disease is suspected or when revascularization decisions are needed. AHA Journals

24. Chest X-ray
    Checks heart size, lung congestion, device leads, and calcification clues; supportive but not diagnostic by itself. Oxford Academic

Non-pharmacological treatments (therapies & others)

Each item includes a short description, purpose, and mechanism in simple words.

1. Observation with safety planning (first-degree or Mobitz I without symptoms) – Doctors may simply watch and avoid triggers, because many mild blocks cause no harm. Purpose: keep you safe without unnecessary procedures. Mechanism: your own normal pacemaker in the atrium still drives the heart; no device is needed unless symptoms appear or the block worsens. HRS

2. Stop or reduce AV-node–slowing medicines – If a beta-blocker, verapamil/diltiazem, digoxin, or certain antiarrhythmics caused the block, stopping or lowering them can restore conduction. Purpose: remove the cause. Mechanism: taking away drugs that slow the AV node lets electrical signals pass normally again. HRS

3. Correct electrolytes (especially high potassium) – Treat hyperkalemia promptly (IV calcium, insulin-glucose, etc.) and replete magnesium as needed. Purpose: prevent dangerous pauses/asystole. Mechanism: normal potassium and calcium stabilize the heart’s electrical membrane and improve conduction. Mayo Clinic Proceedings+1

4. Treat hypoxia and acid–base problems – Oxygen and fixing underlying illness (e.g., pneumonia) can resolve bradycardia. Purpose: restore safe oxygen delivery. Mechanism: adequate oxygen and normal pH help the AV node work better. cpr.heart.org

5. Manage sleep apnea with CPAP – In people with OSA, CPAP often reduces or eliminates nocturnal AV block/pauses. Purpose: stop night-time slow heart rhythms. Mechanism: CPAP prevents airway collapse, cuts vagal surges, and stabilizes heart rate during sleep. AHA Journals+1

6. Temporary transcutaneous pacing (pads) – In emergencies with unstable bradycardia, external pacing pads can keep a safe rate until a better solution is in place. Purpose: bridge to recovery or permanent pacing. Mechanism: skin pads deliver timed impulses to trigger ventricular beats. cpr.heart.org

7. Temporary transvenous pacing – A pacing wire placed through a vein to the right ventricle provides reliable beats in high-grade block while causes are treated. Purpose: stabilize circulation. Mechanism: direct electrical impulses capture the ventricle at a safe rate. HRS

8. Permanent pacemaker (PPM) – The standard treatment for persistent symptomatic Mobitz II or complete heart block. Purpose: prevent fainting, heart failure, and sudden death risk from long pauses. Mechanism: a device senses slow rhythms and delivers beats at a set minimum rate. HRS

9. Conduction-system pacing (His-bundle or left bundle branch area pacing) – A modern way to pace in or near the heart’s natural wiring to keep pumping more natural. Purpose: reduce pacing-related weakening of the heart. Mechanism: precisely placed leads engage the His/LBB fibers to maintain synchronized contraction. Heart Rhythm Journal+1

10. Leadless pacemaker – A tiny pacemaker implanted through a leg vein directly into the heart (no leads under the skin). Purpose: reduce lead/ pocket complications, useful when veins are limited or infection risk is high. Mechanism: the capsule contains the battery and circuitry to pace the ventricle; new systems can coordinate two chambers. PMC+1

11. Cardiac resynchronization therapy (CRT) when also indicated – For patients who need pacing and have weak hearts and wide QRS, CRT can improve symptoms. Purpose: improve pumping efficiency. Mechanism: coordinates left and right ventricle contraction. ScienceDirect

12. Lifestyle adjustments – Stay hydrated, avoid excessive alcohol, and avoid “sudden standing” in people with vagal-triggered Mobitz I; this reduces fainting. Purpose: reduce triggers. Mechanism: keeps blood pressure and autonomic tone steadier. HRS

13. Education on warning signs – Teach family how to call emergency services for fainting, chest pain, or confusion with slow pulse. Purpose: early care saves lives. Mechanism: faster treatment reduces complications. HRS

14. Cardiac rehab/graded activity (after ischemic causes) – Once stabilized, supervised exercise rebuilds stamina safely. Purpose: restore function. Mechanism: monitored activity improves cardiovascular conditioning without provoking bradycardia. HRS

15. Treat underlying diseases (e.g., sarcoidosis) – Immunosuppression plus device therapy when needed. Purpose: prevent recurrent inflammation-related block. Mechanism: reduces granulomatous damage in the conduction system. AHA Journals

16. Antibiotics for Lyme carditis – Appropriate antibiotic course often reverses AV block over days to weeks; temporary pacing may be needed. Purpose: eradicate infection and recover conduction. Mechanism: killing Borrelia reduces inflammation around the AV node. Infectious Diseases Society of America+1

17. Avoid high-risk over-the-counter drugs – Some cold remedies or eye drops include beta-agonists/antagonists interacting with heart meds; pharmacist review helps. Purpose: reduce drug-related slow heart rates. Mechanism: avoid AV-node effects or drug-drug interactions. HRS

18. Electrolyte-sparing diet guidance – For kidney disease, structured diet helps keep potassium in range and prevent recurrent AV block from hyperkalemia. Purpose: prevent repeats. Mechanism: dietary potassium control + medical plan stabilizes conduction. PMC

19. Fall-risk prevention – Until pacing or resolution, use support when walking, avoid ladders, and sit to shower to prevent injury from syncope. Purpose: reduce harm. Mechanism: minimizes trauma from sudden blackouts. HRS

20. Follow-up & remote device monitoring – Regular checks (or remote telemetry) make sure pacemaker settings and battery are right and that block has not recurred. Purpose: maintain long-term safety. Mechanism: continuous oversight catches issues early. HRS

---

Drug treatments

Medicines do not cure fixed high-grade AV block; they stabilize you or treat a reversible cause while you receive pacing or disease-specific therapy. Doses below are typical adult ACLS/clinical references; individual care varies by clinician judgment.

1. Atropine (for symptomatic bradycardia) – Class: anticholinergic. Dose: 1 mg IV bolus; repeat every 3–5 min (max 3 mg). Timing: immediate rescue for unstable slow rhythms, often less effective in Mobitz II/complete block but still used first if available. Purpose: raise heart rate. Mechanism: blocks vagus (parasympathetic) effect on AV node. Side effects: dry mouth, blurry vision, confusion, flushing; rarely worsens ischemia. cpr.heart.org

2. Epinephrine infusion – Class: catecholamine. Dose: 2–10 mcg/min IV, titrate to response. Timing: if atropine fails or while waiting for pacing. Purpose: increase rate and blood pressure. Mechanism: beta-1 stimulation increases automaticity and conduction. Side effects: chest pain, tremor, arrhythmias, high BP. cpr.heart.org

3. Dopamine infusion – Class: catecholamine. Dose: 5–20 mcg/kg/min IV. Timing: alternative to epinephrine for bradycardia with hypotension. Purpose: support circulation. Mechanism: beta-1/inotropic and some alpha effects at higher doses. Side effects: arrhythmias, nausea, ischemia of extremities. cpr.heart.org+1

4. Isoproterenol – Class: beta-agonist. Dose: commonly 2–10 mcg/min IV (specialist use). Timing: temporary bridge in complete heart block when pacing not yet available. Purpose: raise rate. Mechanism: beta-1 stimulation speeds SA node/AV conduction. Side effects: tachyarrhythmias, ischemia; used with monitoring. HRS

5. Glucagon (beta-blocker overdose) – Class: hormone. Dose: e.g., 3–5 mg IV bolus then infusion per toxicology protocol. Timing: AV block from beta-blocker poisoning. Purpose: bypass blocked beta-receptors. Mechanism: increases cAMP independent of beta-receptors. Side effects: nausea, vomiting, hyperglycemia. cpr.heart.org

6. Calcium chloride/gluconate (CCB overdose or hyperkalemia) – Class: membrane stabilizer. Dose: CaCl₂ 10% 1 g IV or Ca-gluconate 3 g IV; repeat if needed. Timing: immediately for ECG changes with hyperkalemia or CCB toxicity. Purpose: stabilize the heart. Mechanism: raises threshold to depolarize, counteracting potassium or CCB effects. Side effects: local irritation; avoid extravasation. Mayo Clinic Proceedings

7. Insulin with dextrose (hyperkalemia) – Class: shifts K⁺. Dose: regular insulin 10 units IV with dextrose (e.g., 25–50 g). Timing: rapid K⁺ lowering when ECG shows AV block/peaked T waves. Purpose/mechanism: drives K⁺ into cells to improve conduction. Side effects: hypoglycemia—monitor glucose. ScienceDirect

8. Nebulized albuterol (hyperkalemia adjunct) – Class: beta-2 agonist. Dose: 10–20 mg nebulized. Purpose: additional K⁺ shift. Mechanism: beta-2 stimulation moves K⁺ into cells. Side effects: tremor, tachycardia; not monotherapy. ACEP

9. Doxycycline (Lyme carditis) – Class: tetracycline antibiotic. Dose: typical adult 100 mg orally twice daily (regimens vary). Timing: mild-moderate disease; IV ceftriaxone preferred if severe AV block. Purpose: eradicate Borrelia. Mechanism: inhibits protein synthesis. Side effects: GI upset, photosensitivity. Infectious Diseases Society of America

10. Ceftriaxone (Lyme carditis with high-grade block) – Class: third-gen cephalosporin. Dose: 2 g IV daily (typical). Timing: hospitalized patients with advanced block; step down to oral after improvement. Purpose/mechanism: bactericidal beta-lactam. Side effects: diarrhea, biliary sludging (rare). PMC

11. Amoxicillin or cefuroxime (Lyme in pregnancy/selected cases) – alternatives guided by guidelines. Purpose: effective and safer in pregnancy. Mechanism/side effects: common penicillin/cephalosporin profile. Drug Information Group

12. Corticosteroids (cardiac sarcoidosis with AV block) – Class: immunosuppressant. Dose: specialist-directed (e.g., prednisone, taper). Purpose: reduce inflammation and prevent progression; many still need pacing/ICD. Mechanism: dampens granulomatous inflammation. Side effects: glucose rise, infection risk, bone loss. AHA Journals

13. Other immunosuppressants for sarcoid (methotrexate, azathioprine, etc.) – steroid-sparing when needed under subspecialty care. Purpose: maintain control of inflammation. Mechanism: various immune pathways. Side effects: drug-specific monitoring required. AHA Journals

14. Theophylline (select elderly with symptomatic sinus node disease/chronotropic incompetence) – occasionally considered when pacing not possible. Purpose: raise heart rate modestly. Mechanism: adenosine receptor antagonism; increases sinus rate/AV conduction. Side effects: nausea, tremor, arrhythmias; narrow therapeutic window. HRS

15. Anticoagulation (only if comorbid AF) – AV block alone isn’t an indication; but if atrial fibrillation coexists, stroke prevention may be needed. Purpose: prevent clot-related stroke. Mechanism: inhibits clotting; drug choice based on CHA₂DS₂-VASc. Side effects: bleeding. HRS

16. Antibiotics for endocarditis (if abscess causing block) – prolonged IV therapy tailored to cultures. Purpose: control infection and stop progression of block. Mechanism: bactericidal therapy. Side effects: drug-specific. HRS

17. Thyroid hormone replacement (hypothyroidism-related bradycardia) – careful titration in cardiac patients. Purpose: normalize metabolism and conduction. Mechanism: restores sympathetic responsiveness. Side effects: palpitations if over-replaced. HRS

18. Antimyocarditis care (when inflammatory) – supportive care +/- immunosuppression in selected etiologies. Purpose: allow recovery of conduction. Mechanism: reduces inflammatory injury. Side effects: therapy-specific. HRS

19. Antidotes for CCB overdose (high-dose insulin euglycemia therapy, lipid emulsion in refractory cases) – in toxicology settings. Purpose: restore contractility/AV conduction. Mechanism: metabolic support for myocytes. Side effects: hypoglycemia risk, monitor closely. Mayo Clinic Proceedings

20. Analgesia/anxiolysis during external pacing – not treating the block itself, but improves tolerance of emergency measures. Purpose: comfort and safety. Mechanism: reduces stress and movement that can disrupt capture. Side effects: respiratory depression if over-sedated. cpr.heart.org

---

Dietary molecular supplements

There are no supplements that “cure” AV block. Focus is on supporting heart health and preventing electrolyte triggers. Always check with your clinician—some supplements interact with cardiac drugs.

1. Electrolyte balance (dietary potassium within plan for kidney health) – For patients prone to high K⁺, dietitian-guided potassium intake helps prevent recurrent hyperkalemia-related block. PMC

2. Magnesium (dietary sufficiency) – Adequate Mg²⁺ helps stabilize heart rhythm; deficiency can worsen arrhythmias. Supplement only if deficient and clinician-approved. PMC

3. Omega-3 fatty acids (food-first approach) – May support general cardiovascular health; not a treatment for AV block. HRS

4. Vitamin D (correct deficiency) – Supports overall cardiovascular and immune health; no direct effect on AV conduction. HRS

5. B-complex (if documented deficiency) – Severe B-12 deficiency can cause neuropathy and fatigue; correcting deficiency supports overall health. HRS

6. Coenzyme Q10 (optional) – Popular but evidence for conduction disease is limited; discuss with a clinician. HRS

7. Avoid stimulant supplements (e.g., high-dose caffeine/“pre-workouts”) – can provoke other rhythm issues and interact with medicines. HRS

8. Avoid unregulated “heart rhythm boosters” – These may contain hidden beta-blockers/agonists and are risky. HRS

9. Hydration with balanced fluids – dehydration can worsen presyncope; aim for steady intake unless fluid-restricted. HRS

10. Limit alcohol – excess can trigger rhythm problems and mask symptoms. HRS

---

Immunity booster / regenerative / stem-cell drugs

There are no approved immune-booster or stem-cell drugs that repair the AV node or His-Purkinje system in humans today. Research into biological pacemakers (gene or cell therapy to create beating cells) is active in animals and early feasibility work, but it is experimental, not standard care. Takeaway: for persistent high-grade AV block, pacemakers (increasingly including conduction-system and leadless options) remain the proven therapy. BioMed Central+2MDPI+2

1. Gene-based biological pacemaker (e.g., HCN2/TBX18 in animals) – aims to make heart cells pace on their own; promising large-animal data exist, but no clinical approval and open scientific debate continues. BioMed Central+1
2. Stem-cell–derived pacemaker cells – iPSC-derived pacemaker-like cells are being engineered, but translation remains early-stage. MDPI+1
3. Mesenchymal stem cells & conduction repair (preclinical) – animal models showed improved AV conduction; not a human therapy yet. PMC
4. Tissue engineering the conduction system – bioengineering approaches are being studied but are preclinical. Frontiers
5. General stem-cell therapy for heart muscle – decades of trials show limited benefit for conduction problems; not used for AV block. AHA Journals
6. Regeneration science – basic research shows neonatal hearts can regenerate conduction pathways after injury; this informs future therapies but not current care. Nature

---

Procedures/surgeries

1. Permanent dual-chamber pacemaker implantation – Through a small chest incision, leads are guided into the heart and a generator is placed under the skin. Why: standard of care for symptomatic Mobitz II or complete heart block to prevent syncope and heart failure. HRS

2. Conduction-system pacing (His-bundle or left bundle branch area) – Leads are placed to capture the native wiring for more natural activation. Why: may reduce pacing-induced cardiomyopathy and improve outcomes in selected patients. Heart Rhythm Journal+1

3. Leadless pacemaker implantation – A capsule-sized device is delivered via a femoral vein into the right ventricle; newer systems can coordinate with an atrial device for AV synchrony. Why: avoids pocket/lead issues and is useful when venous access is limited or infection risk is high. PMC+1

4. Cardiac resynchronization therapy (CRT-P/CRT-D) – For patients needing pacing who also have heart failure and wide QRS; adds a left-sided lead. Why: improve symptoms and survival in appropriate patients. ScienceDirect

5. Atrioventricular node ablation with pacing (special situations) – Used for uncontrolled atrial fibrillation with rapid rates when drugs fail; not to treat AV block but can be relevant in complex rhythm care. Why: symptom control and rate regularization with a pacemaker. ScienceDirect

---

Preventions

1. Regular medication review to avoid unnecessary AV-node blockers or interactions. HRS

2. Manage blood pressure, cholesterol, and diabetes to reduce ischemic damage to the conduction system. HRS

3. Treat sleep apnea to reduce nocturnal bradyarrhythmias. AHA Journals

4. Electrolyte vigilance if you have kidney disease (plan for potassium & magnesium). PMC

5. Prompt care for tick bites/early Lyme according to guidelines. Infectious Diseases Society of America

6. Follow instructions after heart surgery/TAVR, with early reporting of dizziness or syncope. HRS

7. Heart-healthy lifestyle (exercise within advice, quit smoking, limit alcohol). HRS

8. Keep pacemaker checks if you have one (in-person or remote). HRS

9. Vaccinations and infection prevention if you’re on immunosuppressants for sarcoidosis. AHA Journals

10. Know emergency signs (fainting, chest pain, new confusion with slow pulse). HRS

---

When to see a doctor

Seek urgent care now if you faint, nearly faint repeatedly, feel severe weakness or confusion with a very slow pulse, or have chest pain or breathlessness. These can signal high-grade AV block that needs immediate treatment and possibly pacing. Even milder symptoms—unusual fatigue, exercise intolerance, or pauses/palpitations—deserve prompt medical evaluation and an ECG to identify the type of block and the right treatment plan. HRS

---

What to eat / what to avoid

1. Balanced meals with adequate fluids (unless told to restrict) to avoid dehydration-related dizziness. HRS

2. Kidney-friendly potassium plan if you’re at risk—work with a dietitian. PMC

3. Magnesium-containing foods (leafy greens, nuts) as part of a normal diet; avoid unapproved high-dose pills. PMC

4. Limit alcohol; excess can worsen rhythm issues. HRS

5. Heart-healthy pattern (Mediterranean-style) for overall cardiovascular wellness. HRS

6. Avoid stimulant “energy” products that may trigger other arrhythmias. HRS

7. Mind salt intake if you have hypertension or heart failure along with AV block. HRS

8. Be careful with grapefruit if you take certain heart medicines (drug interactions). HRS

9. Avoid unregulated “natural rhythm boosters”—they may contain harmful substances. HRS

10. Consistent meal timing helps avoid large autonomic swings after heavy meals. HRS

---

FAQs

1) Is first-degree AV block dangerous?
Usually no. It means the signal is delayed, not blocked. Most people need only observation and avoiding trigger drugs. Merck Manuals

2) Which types are dangerous?
Mobitz II and complete (third-degree) block are high-risk and generally need a pacemaker. HRS

3) Can medicines fix AV block permanently?
They can stabilize you or reverse causes (e.g., Lyme, high potassium), but fixed high-grade block usually needs a pacemaker. cpr.heart.org+1

4) What does the ACLS algorithm recommend in emergencies?
Atropine 1 mg IV (repeat to 3 mg), then epinephrine or dopamine infusion, and pacing if needed. cpr.heart.org

5) If Lyme disease causes my block, will it go away?
Often yes, with the right antibiotic course; some need temporary pacing during recovery. Infectious Diseases Society of America

6) What is conduction-system pacing?
Pacing the His or left bundle area to mimic natural wiring and maintain better pumping. Heart Rhythm Journal

7) What is a leadless pacemaker?
A small device implanted inside the heart without leads under the skin; newer systems can coordinate two chambers. PMC+1

8) Will a pacemaker stop me from exercising?
Most people return to normal activities after healing; your team programs safe settings for exercise. HRS

9) Can sleep apnea cause night-time AV block?
Yes. Treating with CPAP often reduces bradyarrhythmias. AHA Journals

10) Do supplements help?
No supplement cures AV block. Focus on diet, hydration, and avoiding risky over-the-counter products. PMC

11) Are “biological pacemakers” available?
Not yet—research is promising in animals, but it’s experimental in humans. BioMed Central

12) Can AV block cause heart failure?
Yes, repeated long pauses and dyssynchrony can worsen heart function; pacing prevents this. HRS

13) Is AV block the same as bundle branch block?
No. AV block is between atria and ventricles; bundle branch block is within the ventricles’ wiring. Cleveland Clinic

14) How long is antibiotic treatment for Lyme carditis?
Typically 14–21 days, regimen depends on severity and patient factors. Infectious Diseases Society of America

15) Are there newer guidelines about pacing approaches?
Yes—recent HRS/APHRS/LAHRS guidance adds recommendations for left bundle branch area pacing and expands conduction-system pacing indications. PMC

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 25, 2025.